122310 — Genoray Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapNeutral

Annual income statement for Genoray Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	65,106	61,688	74,290	82,604	97,897
Cost of Revenue
Gross Profit	29,196	25,977	30,992	35,261	37,544
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Total Operating Expenses	50,438	50,569	59,323	67,686	85,140
Operating Profit	14,668	11,119	14,968	14,918	12,757
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	14,982	10,700	15,787	15,704	12,961
Provision for Income Taxes
Net Income After Taxes	13,240	10,172	14,323	13,900	12,356
Minority Interest
Net Income Before Extraordinary Items
Net Income	13,240	10,172	14,323	13,900	12,486
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	13,399	10,172	14,323	13,900	12,486
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	917	709	999	987	911
Dividends per Share